Collegium Pharmaceutical, Inc.: how funds voted at the meeting of 15 May 2025
- Ticker
- COLL
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 386
- Ballot items
- 5
386 filers on Form N-PX reported votes at the Collegium Pharmaceutical, Inc. meeting of 15 May 2025. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Collegium Pharmaceutical, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
8 nominees. 97.5% of the reported votes are for. 8 filers withheld from or voted against at least one nominee.
2,146 vote records from 139 filers. 1 of the 139 filers that marked the item voted against management.
- Positions of 44 fund families
- For 44
Item 2: Advisory vote on executive pay (say-on-pay)
556 vote records from 383 filers. 39 of the 369 filers that marked the item voted against management. 14 filers gave no management mark.
- Positions of 49 fund families
- For 45
- Against 4
- Against management 4
Item 3: Frequency of the say-on-pay vote
One year: 350 filers. Three years: 9 filers. For: 3 filers. Abstain: 3 filers. 1-year: 2 filers. Takenoaction: 1 filer.
550 vote records from 379 filers. 11 of the 364 filers that marked the item voted against management. 15 filers gave no management mark.
- Positions of 49 fund families
- Split or no vote 49
- Against management 1
Item 4: Audit-related items (auditor ratification)
269 vote records from 139 filers. 4 of the 139 filers that marked the item voted against management.
- Positions of 44 fund families
- For 44
Item 5: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
276 vote records from 142 filers. 53 of the 142 filers that marked the item voted against management.
- Positions of 44 fund families
- For 25
- Against 19
- Against management 19
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Pay-vote frequency | 4. Auditor |
|---|---|---|---|
| AllianceBernstein | For | Split | No report |
| Allspring | For | Split | For |
| American Beacon | For | Split | For |
| American Century | Against, against management | Split | For |
| BlackRock and iShares | For | Split | For |
| BNY Mellon | For | Split | For |
| Brighthouse Funds | For | Split | For |
| Charles Schwab | For | Split | For |
| Columbia Threadneedle | Against, against management | Split | For |
| Dimensional | For | Split, against management | For |
| DWS | For | Split | For |
| Equitable | For | Split | For |
| Federated Hermes | For | Split | No report |
| Fidelity | For | Split | For |
| First Trust | For | Split | For |
| Franklin Templeton | For | Split | For |
| Global X | For | Split | For |
| Goldman Sachs | For | Split | For |
| Guggenheim and Rydex | For | Split | For |
| Harbor Funds | For | Split | For |
| Invesco | Against, against management | Split | For |
| J.P. Morgan | For | Split | For |
| Jackson National funds | For | Split | For |
| Janus Henderson | For | Split | For |
| John Hancock and Manulife | For | Split | For |
| Lincoln Financial | For | Split | For |
| MassMutual | Against, against management | Split | For |
| MFS | For | Split | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Split | For |
| Nationwide | For | Split | For |
| Natixis and Loomis Sayles | For | Split | For |
| Neuberger Berman | For | Split | No report |
| Northern Trust and FlexShares | For | Split | For |
| Nuveen and TIAA | For | Split | For |
| Pacific Life funds | For | Split | For |
| PGIM and Prudential | For | Split | For |
| PIMCO | For | Split | No report |
| Principal | For | Split | For |
| ProShares and ProFunds | For | Split | For |
| Russell Investments | For | Split | No report |
| SEI | For | Split | For |
| State Street and SPDR | For | Split | For |
| T. Rowe Price | For | Split | For |
| Thrivent | For | Split | For |
| Vanguard | For | Split | For |
| Victory Capital | For | Split | For |
| Virtus | For | Split | For |
| Voya | For | Split | For |
| WisdomTree | For | Split | For |
Questions
- How many filers reported votes at the Collegium Pharmaceutical, Inc. meeting?
- 386 Form N-PX filers reported votes at the meeting of 15 May 2025. On say-on-pay, 39 of 369 filers that marked the item voted against management (10.6%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Collegium Pharmaceutical, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Collegium Pharmaceutical, Inc. with a meeting date within three days of 15 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .